{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:38:54Z","timestamp":1784068734596,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006870.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000}}],"reference-count":137,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006870.pub3","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T14:33:09Z","timestamp":1409581989000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Statins for acute coronary syndrome"],"prefix":"10.1002","volume":"2015","author":[{"given":"Noah","family":"Vale","sequence":"first","affiliation":[{"name":"St Mary's Hospital, McGill University; Family Medicine; 377 Rue Jean Brilliant Montreal QC Canada H3T 1M5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain J","family":"Nordmann","sequence":"additional","affiliation":[{"name":"University Hospital Basel; Institute for Clinical Epidemiology and Biostatistics; Hebelstrasse 10 Basel Switzerland 4031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G","family":"Schwartz","sequence":"additional","affiliation":[{"name":"VA Medical Center and University of Colorado; 1055 Clermont St Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"de Lemos","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical School; Cardiology\/Internal Medicine; 5909 Harry Hines Blvd Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[{"name":"S. Filippo Neri Hospital; Cardiovascular Department; 330 Viale Gorgia da Leontini Rome Italy 00124"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"den Hartog","sequence":"additional","affiliation":[{"name":"Gelderse Vallei Hospital; Cardiology Department; postbus 9025 Ede Netherlands 6710 HN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Ostadal","sequence":"additional","affiliation":[{"name":"Na Homolce Hospital; Department of Cardiology; Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M","family":"Macin","sequence":"additional","affiliation":[{"name":"Instituto de Cardiologia; Coronary Intensive Care Unit; Juana F Cabrel Corrientes Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anho H","family":"Liem","sequence":"additional","affiliation":[{"name":"Franciscus Gasthuis Rotterdam; Department of Cardiology; Rotterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J","family":"Mills","sequence":"additional","affiliation":[{"name":"University of Ottawa; Faculty of Health Sciences; 451 Smyth Road Ottawa ON Canada K1H 8M5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Clinical Epidemiology and Biostatistics; 1200 Main Street West Hamilton ON Canada L8N 3Z5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner C","family":"Bucher","sequence":"additional","affiliation":[{"name":"University Hospital Basel (USB); Basel Institute for Clinical Epidemiology and Biostatistics; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Briel","sequence":"additional","affiliation":[{"name":"University Hospital Basel (USB); Basel Institute for Clinical Epidemiology and Biostatistics; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD006870.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"872\u20134","DOI":"10.1016\/S0002-9149(02)02711-X","article-title":"Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction","volume":"90","author":"Colivicchi","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"Lemos","year":"2004","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD006870.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1468-6708-6-4","article-title":"Fluvastatin in the therapy of acute coronary syndrome: rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)","volume":"6","author":"Ostadal","year":"2005","journal-title":"Current Controlled Trials in Cardiovascular Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1745-6215-11-61","article-title":"Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)","volume":"11","author":"Ostadal","year":"2010","journal-title":"Trials"},{"issue":"24","key":"10.1002\/14651858.CD006870.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1053\/euhj.2002.3291","article-title":"Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial","volume":"23","author":"Liem","year":"2002","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0007|cit7","first-page":"107\u201316","article-title":"Time course of serum lipids and apolipoproteins after acute myocardial infarction: modification by pravastatin","volume":"52","author":"Kesteloot","year":"1997","journal-title":"Acta Cardiologica"},{"issue":"12","key":"10.1002\/14651858.CD006870.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1293\u20138","DOI":"10.1016\/S0002-9149(00)01230-3","article-title":"Beneficial effects of pravastatin (+\/- colestyramine\/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study)","volume":"86","author":"Arntz","year":"2000","journal-title":"American Journal of Cardiology"},{"issue":"24","key":"10.1002\/14651858.CD006870.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"451\u20137","DOI":"10.1016\/j.ahj.2004.07.041","article-title":"Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study","volume":"149","author":"Macin","year":"2005","journal-title":"American Heart Journal"},{"issue":"13","key":"10.1002\/14651858.CD006870.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1253\/circj.72.17","article-title":"Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID study","volume":"72","author":"Sato","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2003.10.052","article-title":"Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial","volume":"148","author":"Thompson","year":"2004","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD006870.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1742-1241.2001.tb11043.x","article-title":"Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial","volume":"55","author":"Hartog","year":"2001","journal-title":"International Journal of Clinical Practice"},{"issue":"17","key":"10.1002\/14651858.CD006870.pub3-BIB0015|cit15","first-page":"2339","article-title":"Reductions in early recurrent coronary ischemia from early administration of statin therapy upon admission for myocardial infarction: results of the PRINCESS trial","volume":"110","author":"LaBlanche","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0016|cit16","unstructured":"Wright RS PRINCESS: Prevention of ischaemic events by early treatment of cerivastatin after acute myocardial infarction Hotline session III, European Society of Cardiology 2004"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0018|cit17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-5273(02)00516-8","article-title":"The effect of statin therapy on ventricular late potentials in acute myocardial infarction","volume":"90","author":"Kayikcioglu","year":"2003","journal-title":"International Journal of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006870.pub3-BIB0019|cit18","first-page":"I-303. Abstract","article-title":"The short term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction [abstract]","volume":"100","author":"Kayikcioglu","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006870.pub3-BIB0020|cit19","first-page":"1","article-title":"Combined use of pravastatin and thrombolytic agents in acute myocardial infarction. Pravastatin turkish trial (PTT)","volume":"100","author":"Kayikcioglu","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0017|cit20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2143\/AC.57.4.2005430","article-title":"Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty","volume":"57","author":"Kayik\u00e7io\u011flu","year":"2002","journal-title":"Acta Cardiologica"},{"issue":"25","key":"10.1002\/14651858.CD006870.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0022|cit22","first-page":"E280","article-title":"Effect of simvastatin on plasma interleukin-6 in patients with unstable angina","volume":"32","author":"Ren","year":"2009","journal-title":"Clinical and Investigative Medicine. M\u00e9decine Clinique et Experimentale"},{"issue":"8","key":"10.1002\/14651858.CD006870.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1165\u201371","DOI":"10.1016\/j.amjcard.2005.11.031","article-title":"Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese","volume":"97","author":"Sakamoto","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0024|cit24","first-page":"46","article-title":"The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome","volume":"85","author":"Shal'nev","year":"2007","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0025|cit25","first-page":"355","article-title":"Effect of intensive vs. moderate lipid-lowering therapy with atorvastatin on the stabilization of atherosclerosis in acute coronary syndromes: serial optical coherence tomography analysis","volume":"33","author":"Akasaka","year":"2012","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD006870.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/pmic.200700583","article-title":"Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome","volume":"9","author":"Barderas","year":"2009","journal-title":"Proteomics"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0027|cit27","first-page":"143\u201353","article-title":"Summary of the Clinical Studies Reported in the Scientific Sessions in the American Heart Association 2005 (Dallas, Texas, USA, 13\u201316 November 2005)","volume":"59","author":"Bermejo","year":"2006","journal-title":"Revista Espanola de Cardiologia (Internet)"},{"issue":"15","key":"10.1002\/14651858.CD006870.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0029|cit29","first-page":"144","article-title":"Long-term effects of simvastatin on protection against atrial fibrillation in patients with acute myocardial infarction","volume":"4","author":"Chi","year":"2007","journal-title":"Journal of Geriatric Cardiology"},{"issue":"16","key":"10.1002\/14651858.CD006870.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/eurheartj\/ehm196","article-title":"Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study","volume":"28","author":"Chiodini","year":"2007","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.carrev.2009.11.001","article-title":"Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome","volume":"12","author":"Chyrchel","year":"2011","journal-title":"Cardiovascular Revascularization Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006870.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1185\/03007991003751496","article-title":"Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease","volume":"26","author":"Colivicchi","year":"2010","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1185\/03007991003751496","article-title":"Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease","volume":"26","author":"Colivicchi","year":"2010","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0034|cit34","first-page":"15S","article-title":"Full-dose atorvastatin reduces hospitalizations for heart failure after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease","volume":"1","author":"Colivicchi","year":"2011","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9149(02)02443-8","article-title":"Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction","volume":"90","author":"Correia","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"Winter","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2009.12.001","article-title":"Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study","volume":"210","author":"Dohi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0038|cit38","first-page":"II_650","article-title":"Early treatment with simvastatin in myocardial infarction to reduce the levels of multiple inflammatory markers in 6-month follow-up. FLAME randomized clinical trial","volume":"114","author":"Wojakowski","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jjcc.2009.12.002","article-title":"Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes","volume":"55","author":"Ge","year":"2010","journal-title":"Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD006870.pub3-BIB0040|cit40","first-page":"325\u20138","article-title":"Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium)","volume":"126","author":"G\u00f3mez-Doblas","year":"2006","journal-title":"Medicina Clinica"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2008.02.090","article-title":"Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome","volume":"102","author":"G\u00f3mez-Hern\u00e1ndez","year":"2008","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD006870.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"454\u201362","DOI":"10.1111\/j.1365-2362.2007.01805.x","article-title":"Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients","volume":"37","author":"Guazzi","year":"2007","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/HJR.0b013e3283316ce8","article-title":"A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial","volume":"16","author":"Hall","year":"2009","journal-title":"European Journal of Cardiovascular Prevention & Rehabilitation"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/clc.20818","article-title":"The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome","volume":"34","author":"He","year":"2011","journal-title":"Clinical Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"293\u2013302","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)","volume":"54","author":"Hiro","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","article-title":"Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)","volume":"54","author":"Hiro","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1253\/circj.CJ-09-0766","article-title":"Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial)","volume":"74","author":"Hiro","year":"2010","journal-title":"Circulation Journal"},{"issue":"5","key":"10.1002\/14651858.CD006870.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"291\u20137","DOI":"10.1007\/s00380-005-0901-1","article-title":"The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol","volume":"21","author":"Kanada\u015f\u0131","year":"2006","journal-title":"Heart and Vessels"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"76\u20139","DOI":"10.1016\/j.jjcc.2009.04.008","article-title":"Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study","volume":"54","author":"Kashima","year":"2009","journal-title":"Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0050|cit50","first-page":"21","article-title":"Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation","volume":"50","author":"Kuznetsova","year":"2010","journal-title":"Kardiologiia"},{"issue":"6","key":"10.1002\/14651858.CD006870.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"399\u2013406","DOI":"10.1016\/j.acvd.2008.05.010","article-title":"Effects of rosuvastatin and atorvastatin on the apolipoprotein B\/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: the CENTAURUS trial design","volume":"101","author":"Lablanche","year":"2008","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"Suppl A, Februa","key":"10.1002\/14651858.CD006870.pub3-BIB0052|cit52","first-page":"A197","article-title":"Early treatment with fluvastatin enhances the mobilization of CD34+, CD117+, CXCR4+, C-met+ stem cells into peripheral blood in patients with acute myocardial infarction: LAVA trial","volume":"45","author":"Wojakowski","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"479\u201386","DOI":"10.1016\/j.ijcard.2003.11.031","article-title":"Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease","volume":"98","author":"Lemos","year":"2005","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2008.05.036","article-title":"Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial","volume":"130","author":"Leone","year":"2008","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD006870.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1373\/clinchem.2005.049700","article-title":"Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina","volume":"51","author":"Li","year":"2005","journal-title":"Clinical Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0056|cit56","first-page":"529","article-title":"Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina","volume":"92","author":"Li","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.amjcard.2012.01.351","article-title":"Effect on short- and long-term major adverse cardiac events of statin treatment in patients with acute myocardial infarction and renal dysfunction","volume":"109","author":"Lim","year":"2012","journal-title":"American Journal of Cardiology"},{"issue":"24","key":"10.1002\/14651858.CD006870.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/eurheartj\/ehl277","article-title":"Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome","volume":"27","author":"Link","year":"2006","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/eurheartj\/ehl277","article-title":"Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome","volume":"27","author":"Link","year":"2006","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00392-010-0225-8","article-title":"Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes","volume":"100","author":"Link","year":"2011","journal-title":"Clinical Research in Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ccd.23171","article-title":"Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design","volume":"79","author":"Liu","year":"2012","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1253\/circj.70.1624","article-title":"Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design","volume":"70","author":"Miyauchi","year":"2006","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0063|cit63","first-page":"93","article-title":"Early effects of lipid lowering treatment in subjects with metabolic syndrome and acute coronary syndromes","volume":"3","author":"Monteiro","year":"2008","journal-title":"International Journal of Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/FJC.0b013e318165dcad","article-title":"Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome","volume":"51","author":"Nakamura","year":"2008","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"67\u201373","DOI":"10.1016\/j.ijcard.2004.12.024","article-title":"Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction","volume":"105","author":"Nakaya","year":"2005","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"282\u20134","DOI":"10.1016\/j.ijcard.2007.06.030","article-title":"Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes","volume":"128","author":"Ordulu","year":"2008","journal-title":"International Journal of Cardiology"},{"issue":"1-2","key":"10.1002\/14651858.CD006870.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1023499727477","article-title":"The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction","volume":"246","author":"Ostadal","year":"2003","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"12","key":"10.1002\/14651858.CD006870.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1272\u20138","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 8, April","key":"10.1002\/14651858.CD006870.pub3-BIB0069|cit69","first-page":"74A","article-title":"Pravastatin early use in acute coronary evaluation (PEACE) trial","volume":"95","author":"Min","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD006870.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0149-2918(00)80066-1","article-title":"Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study","volume":"22","author":"Pedersen","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"19","key":"10.1002\/14651858.CD006870.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD006870.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacc.2007.11.075","article-title":"Lipid levels after acute coronary syndromes","volume":"51","author":"Pitt","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.amjcard.2011.12.015","article-title":"Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study)","volume":"109","author":"Pitt","year":"2012","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ccd.23449","article-title":"Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial","volume":"80","author":"Post","year":"2012","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"193\u20136","DOI":"10.1159\/000089599","article-title":"Rationale and design of the OACIS-LIPID study that evaluates early use of pravastatin in acute myocardial infarction","volume":"5","author":"Sakata","year":"2005","journal-title":"Heart Drug"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0076|cit76","first-page":"91","article-title":"Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions","volume":"12","author":"Shah","year":"2007","journal-title":"Experimental and Clinical Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006870.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijcard.2007.11.025","article-title":"Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation","volume":"133","author":"Stefanadi","year":"2009","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.amjcard.2011.07.009","article-title":"Long-term safety and efficacy of pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS])","volume":"108","author":"Suh","year":"2011","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jjcc.2008.08.008","article-title":"Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction","volume":"53","author":"Teshima","year":"2009","journal-title":"Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2005.05.055","article-title":"The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level","volume":"109","author":"Tousoulis","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006870.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"48\u201352","DOI":"10.1016\/j.ijcard.2005.05.055","article-title":"The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level","volume":"109","author":"Tousoulis","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"333\u20137","DOI":"10.1016\/j.ijcard.2005.02.011","article-title":"Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina","volume":"106","author":"Tousoulis","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD006870.pub3-BIB0083|cit83","first-page":"659\u201364","article-title":"Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome","volume":"122","author":"Xin-wei","year":"2009","journal-title":"Chinese Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2008.06.055","article-title":"The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome","volume":"137","author":"Yun","year":"2009","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1074248412465792","article-title":"Intensive-dose atorvastatin regimen halts progression of atherosclerotic plaques in new-onset unstable angina with borderline vulnerable plaque lesions","volume":"18","author":"Zhang","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"5-6","key":"10.1002\/14651858.CD006870.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1440-1681.2008.05110.x","article-title":"Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina","volume":"36","author":"Zhao","year":"2009","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0087|cit87","article-title":"Early effect of atorvastatin, alone and in combination with probucol, on endothelial dysfunction in patients with acute coronary syndrome","volume":"Conference","author":"Zheng","year":"2009","journal-title":"Atherosclerosis Supplements"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0088|cit88","first-page":"900","article-title":"Effects of atorvastatin, alone and in combination with probucol on endothelial function in patients with acute coronary syndrome","volume":"37","author":"Zheng","year":"2009","journal-title":"Chung-Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology]"},{"issue":"8934","key":"10.1002\/14651858.CD006870.pub3-BIB0089|cit89","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0090|cit90","unstructured":"American Heart Association Heart disease and stroke statistics - 2007 update Available at www.americanheart.org\/statistics"},{"issue":"7","key":"10.1002\/14651858.CD006870.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"issue":"34","key":"10.1002\/14651858.CD006870.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13340","article-title":"Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation","volume":"13","author":"Ara","year":"2009","journal-title":"Health Technology Assessment"},{"issue":"9753","key":"10.1002\/14651858.CD006870.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"issue":"9262","key":"10.1002\/14651858.CD006870.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"issue":"9753","key":"10.1002\/14651858.CD006870.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD006870.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.amjmed.2004.04.022","article-title":"Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials","volume":"117","author":"Briel","year":"2004","journal-title":"American Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD006870.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0098|cit98","unstructured":"Deeks J Bradburn M Localio R Berlin J Much ado about nothing: statistical methods for meta-analysis with rare events 6th Cochrane Colloquium, Baltimore, MD, USA 1998"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"6964","key":"10.1002\/14651858.CD006870.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD006870.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","article-title":"Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality","volume":"96","author":"Fonarow","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"19","key":"10.1002\/14651858.CD006870.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"999","DOI":"10.7326\/0003-4819-124-11-199606010-00008","article-title":"Survivor treatment selection bias in observational studies: examples from the AIDS literature","volume":"124","author":"Glesby","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD006870.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"9326","key":"10.1002\/14651858.CD006870.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"The Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.166.17.1814","article-title":"The effect of early, intensive statin therapy on acute coronary syndrome. A meta-analysis of randomized controlled trials","volume":"166","author":"Hulten","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD006870.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4065\/84.10.917","article-title":"Acute coronary syndromes: diagnosis and management, part I","volume":"84","author":"Kumar","year":"2009","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/9780470317051.ch3","article-title":"Sample size, power, and efficiency","volume-title":"Biostatistical Methods","author":"Lachin","year":"2000"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-140-11-200406010-00014","article-title":"Observational studies of treatment effectiveness: some cautions","volume":"140","author":"Laupacis","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0112|cit112","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"19","key":"10.1002\/14651858.CD006870.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","author":"LIPID Study Group","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"7491","key":"10.1002\/14651858.CD006870.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","article-title":"Validity of composite end points in clinical trials","volume":"330","author":"Montori","year":"2005","journal-title":"BMJ"},{"issue":"15","key":"10.1002\/14651858.CD006870.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.04.093","article-title":"Statins in acute coronary syndromes: do the guideline recommendations match the evidence?","volume":"54","author":"Morrissey","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD006870.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD006870.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0953-6205(00)00110-2","article-title":"Systematic, immediate in-hospital initiation of lipid-lowering drugs during acute coronary events improves lipid control","volume":"11","author":"Nordmann","year":"2000","journal-title":"European Journal of Internal Medicine"},{"issue":"21","key":"10.1002\/14651858.CD006870.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM199805213382106","article-title":"The treatment of unrelated disorders in patients with chronic medical diseases","volume":"338","author":"Redelmeier","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006870.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"20","key":"10.1002\/14651858.CD006870.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD006870.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD006870.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006870.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ahj.2004.06.033","article-title":"Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial","volume":"149","author":"Smith","year":"2005","journal-title":"American Heart Journal"},{"issue":"11","key":"10.1002\/14651858.CD006870.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-140-11-200406010-00006","article-title":"Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study","volume":"140","author":"Spencer","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD006870.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000032033.39301.6A","article-title":"Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit","volume":"22","author":"Sposito","year":"2002","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"issue":"7","key":"10.1002\/14651858.CD006870.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.285.4.430","article-title":"Early statin treatment following acute myocardial infarction and 1-year survival","volume":"285","author":"Stenestrand","year":"2001","journal-title":"JAMA"},{"issue":"7304","key":"10.1002\/14651858.CD006870.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0129|cit129","unstructured":"Stone NJ Robinson J Lichtenstein AH Merz CN Blum CB Eckel RH 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines Circulation 10.1016\/j.jacc.2013.11.002"},{"issue":"7","key":"10.1002\/14651858.CD006870.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archinte.165.7.725","article-title":"Effect of different antilipidemic agents and diets on mortality: a systematic review","volume":"165","author":"Studer","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD006870.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD006870.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1381612043453360","article-title":"Insights into early and rapid effects of statin therapy after coronary interventions","volume":"10","author":"Walter","year":"2004","journal-title":"Current Pharmaceutical Design"},{"issue":"10","key":"10.1002\/14651858.CD006870.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention","volume":"19","author":"Wood","year":"1998","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/jama.295.17.2046","article-title":"Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes. A meta-analysis of randomized controlled trials","volume":"295","author":"Briel","year":"2006","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006870.pub3-BIB0135|cit135","first-page":"856","article-title":"5012 Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a systematic review and collaborative meta-analysis of randomized trials","volume":"27","author":"Briel","year":"2006","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006870.pub3-BIB0136|cit136","unstructured":"Briel M Vale N Schwartz GG de Lemos JA Colivicchi F den Hartog FR Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients International Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD006870.pub3-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006870.pub2","article-title":"Statins for acute coronary syndrome","author":"Vale","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006870.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:48:55Z","timestamp":1716619735000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006870.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":137,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006870.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}